Published in Int J Hepatol on July 12, 2011
Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease. World J Gastroenterol (2016) 0.75
Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction (2002) 9.47
Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med (1989) 4.07
Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology (2000) 3.97
Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol (1998) 3.54
Corticosteroid therapy of alcoholic hepatitis. Gastroenterology (1978) 3.21
A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology (2004) 3.04
MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology (2005) 2.99
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut (2005) 2.62
Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med (1968) 2.23
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol (2005) 2.21
The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology (2007) 2.20
Systematic review: glucocorticosteroids for alcoholic hepatitis--a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther (2008) 2.16
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16
S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol (1999) 2.14
Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl (2006) 2.02
Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA (1999) 1.99
Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl (2007) 1.91
Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF). Dig Dis Sci (2010) 1.87
Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl (2008) 1.83
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut (2010) 1.83
A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol (2004) 1.83
A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J Hepatol (2007) 1.82
Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. J Hepatol (2005) 1.79
A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med (1992) 1.71
A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology (2008) 1.65
Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology (1990) 1.59
Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology (1990) 1.56
Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann Intern Med (1990) 1.38
Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med (1984) 1.30
Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. J Hepatol (2007) 1.26
Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology (2000) 1.23
Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut (1982) 1.19
Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut (1995) 1.13
Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation (1999) 1.05
Clinical syndromes of alcoholic liver disease. Dig Dis (2005) 1.04
Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol (2002) 1.04
S-adenosyl-L-methionine for alcoholic liver diseases. Cochrane Database Syst Rev (2006) 0.98
Spontaneous decrease in portal pressure with clinical improvement in cirrhosis. N Engl J Med (1960) 0.98
Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind randomized study. Am J Dig Dis (1977) 0.95
A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients. Am J Gastroenterol (1978) 0.93
Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation (2001) 0.89
Natural history of alcoholic hepatitis. II. The long-term prognosis. Am J Gastroenterol (1971) 0.88
Alcoholic recidivism after liver transplantation for alcoholic cirrhosis. J Clin Gastroenterol (1998) 0.78
Financial burden of alcohol abuse in patients with alcoholic liver disease. Trop Gastroenterol (2001) 0.76
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology (2007) 4.35
Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria. Liver Transpl (2007) 2.39
Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci (2010) 2.12
Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol (2010) 1.31
Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol (2010) 1.17
Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. World J Gastroenterol (2007) 0.96
Simple organ failure count versus CANONIC grading system for predicting mortality in acute-on-chronic liver failure. J Gastroenterol Hepatol (2015) 0.93
Pancreatic cysts causing biliary obstruction in von Hippel Lindau syndrome. JOP (2008) 0.91
Fungal liver abscess in an immunocompetent individual. Trop Gastroenterol (2013) 0.89
Asians need different criteria for defining overweight and obesity. Arch Intern Med (2005) 0.88
Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis. Metab Brain Dis (2013) 0.88
Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population. Hepatol Int (2010) 0.86
Pitfall in the diagnosis of biliary ascariasis. J Clin Ultrasound (2009) 0.86
Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients. J Med Virol (2013) 0.86
Anaplastic large cell lymphoma presenting as acute liver failure: A report of two cases with review of literature. Ann Hepatol (2010) 0.85
The effect of sedation during upper gastrointestinal endoscopy. Saudi J Gastroenterol (2010) 0.85
Comparison of 7 staging systems in north Indian cohort of hepatocellular carcinoma. Trop Gastroenterol (2011) 0.84
Serum iron levels and hepatic iron overload in patients with nonalcoholic steatohepatitis. Dig Dis Sci (2006) 0.84
APOC3 and PNPLA3 in non-alcoholic fatty liver disease: need to clear the air. J Gastroenterol Hepatol (2012) 0.84
Nonalcoholic fatty liver in a developing country is responsible for significant liver disease. Hepatology (2010) 0.83
Indocyanine green clearance test (using spectrophotometry) and its correlation with model for end stage liver disease (MELD) score in Indian patients with cirrhosis of liver. Trop Gastroenterol (2012) 0.82
Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation. World J Gastroenterol (2007) 0.82
Clinical significance of genotypes and precore/basal core promoter mutations in HBV related chronic liver disease patients in North India. Dig Dis Sci (2009) 0.81
Functional reconstitution of defective myeloid dendritic cells in chronic hepatitis C infection on successful antiviral treatment. Liver Int (2012) 0.81
Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol (2012) 0.80
Primary leiomyosarcoma of gallbladder: a rare diagnosis. Case Rep Gastrointest Med (2012) 0.80
Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma. Mol Cell Biochem (2013) 0.80
Expression of astrocytic genes coding for proteins implicated in neural excitation and brain edema is altered after acute liver failure. J Neurochem (2013) 0.79
Levels of hepatitis B virus replicative intermediate in serum samples of chronic hepatitis B patients. Mol Biol Rep (2014) 0.79
Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension. Dig Dis Sci (2008) 0.78
Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol (2009) 0.78
External stenting of pancreaticojejunostomy anastomosis and pancreatic duct after pancreaticoduodenectomy. Updates Surg (2012) 0.78
Portal hypertension in nodular regenerative hyperplasia: a mixed bag! J Gastroenterol Hepatol (2012) 0.77
Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center. Hepatol Int (2015) 0.77
Nonalcoholic fatty liver disease in India--how much? How soon? Trop Gastroenterol (2005) 0.77
Chronic hepatitis C and diabetes mellitus--are they related? Trop Gastroenterol (2008) 0.77
Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: experience from an Indian center. Clin Chim Acta (2006) 0.77
Angiogenic and anti-angiogenic factor gene transcript level quantitation by quantitative real time PCR in patients with hepatocellular carcinoma. Mol Biol Rep (2013) 0.77
HBV specific T-cell responses in hepatitis B. Trop Gastroenterol (2012) 0.77
Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C. Dig Dis Sci (2011) 0.76
Association of IL28B single nucleotide polymorphism rs8099917 with response to treatment in genotype 3 HCV-infected patients from India. Trop Gastroenterol (2014) 0.76
Non-cirrhotic portal fibrosis (NCPF) is a vanishing disease in India. Trop Gastroenterol (2003) 0.76
What is the association between Helicobacter pylori and hyperammonemia in liver disease? Indian J Gastroenterol (2004) 0.75
Safety and efficacy of ERCP in pregnancy. Gastrointest Endosc (2005) 0.75
Treatment of HCV cirrhosis--simple or not quite so? Trop Gastroenterol (2010) 0.75
Intrahepatic stones: is it a lifestyle disease? J Gastroenterol Hepatol (2008) 0.75
Visual detection of serum asialohaptoglobin by plasmonic sandwich ELLSA - a new platform for cirrhosis diagnosis. Analyst (2015) 0.75
Azathioprine induced liver injury: a case report. Dig Dis Sci (2012) 0.75
Pain, jaundice and lump in a middle-aged man. Indian J Gastroenterol (2007) 0.75
An unusual cause of cholestatic hepatitis: syphilis. Dig Dis Sci (2013) 0.75
Biphasic multidetector CT of primary hepatic lymphoma in a patient with HIV infection. Trop Gastroenterol (2008) 0.75
Nonalcoholic Fatty Liver Disease--The Clinician's Perspective. Trop Gastroenterol (2015) 0.75
Noncirrhotic portal fibrosis and abdominal varices. Liver Int (2010) 0.75
Portal vein aneurysm: is it an incidental finding only? Ann Hepatol (2012) 0.75
Comparative analysis of duodenal biopsy tissue orientation supported on vegetable matrix versus filter paper. Indian J Gastroenterol (2002) 0.75
Retroduodenal perforation without sphincterotomy: a case report. Dig Dis Sci (2010) 0.75
Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers. Trop Gastroenterol (2005) 0.75